Sonoco (SON) Q2 2025 Earnings Call Transcript

Sonoco reported Q2 net sales of $1.9 billion, up 49%, and adjusted EBITDA of $328 million, up 25%, with margins expanding 101 bps to 17.2% on the SMP EMEA acquisition and strong U.S. metal packaging volumes. Management reiterated full-year sales guidance of $7.75 billion-$8.0 billion and EBITDA of $1.3 billion-$1.4 billion, but lowered adjusted EPS expectations to the low end of $6.00-$6.20 and operating cash flow to the low end of range due to higher interest expense and working-capital inflation. The company raised SMP EMEA synergy targets to $40 million-$50 million for 2025, advanced divestitures, and reaffirmed leverage reduction plans, while noting tariff, FX, and European demand risks.

Analysis

SON is now in a classic post-portfolio-surgery rerate window: the business mix is getting cleaner, leverage is falling, and the market is being handed a clearer bridge from acquired EBITDA to cash deleveraging. The subtle point is that the remaining upside is less about headline growth and more about operating-structure simplification; if management actually takes out stranded overhead faster than expected, incremental margin can stay unusually high even if end-market volumes only grow mid-single digits.

The second-order winner is the core packaging franchise, not the acquisition itself. The combination of U.S. metal can tightness, seasonal EMEA recovery, and URB pricing should create a “multiple tailwind + earnings tailwind” setup into Q3/Q4, especially because the market has been conditioned to focus on weak first-half Europe rather than the more important 2026 contract ramp. That means consensus may still be underestimating the duration of volume gains: the new EMEA contracts are not just volume adds, they improve plant utilization and procurement leverage, which should compound synergy capture rather than merely offset it.

The main bear case is that EPS can lag EBITDA longer than investors expect because working capital and interest still consume cash flow, and that makes the stock vulnerable if the macro turns before the synergy/price-mix benefits show through. Tariffs matter less as a direct P&L hit than as a demand-shaping force: the risk is not margin compression so much as retail volume migration and inventory behavior, which could delay the normalization management is counting on. The contrarian view is that the market may be over-fixated on the near-term Europe softness while underappreciating how much of 2026 is already mechanically de-risked by contract wins, procurement integration, and the debt paydown path.

Key Decisions for Investors

• Long SON vs. short a weaker cyclical packaging peer: buy SON and short IP or PKG for 3-6 months; SON has a clearer deleveraging + synergy path while peers face more pure demand exposure.
• Add to SON on any post-earnings pullback if it trades back to the high-teens/low-$20s: risk/reward improves because Q3 seasonality and URB flow-through should show up before the market fully prices 2026 synergy run-rate.
• Buy SON Jan-2026 call spreads to express the deleveraging rerate: upside is driven by multiple expansion if net leverage trends toward the 3-3.3x target and EBITDA continues to print above guidance.
• Hedge the macro/tariff risk by pairing SON long against a retail-demand-sensitive industrial basket; if tariffs slow consumer throughput, SON’s food/packaging mix should prove more resilient than discretionary-linked names.
• Take profits into Q3 if the stock rerates sharply before cash conversion improves: the key risk is that EBITDA optimism outruns EPS/cash flow, creating a temporary valuation gap that can reverse on any working-capital disappointment.